IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland

<p>Abstract</p> <p>Background</p> <p>Two commercial interferon gamma release assays (IGRAs) (QuantiFERON<sup>®</sup>-TB Gold in Tube and T SPOT<sup>®</sup>-<it>TB</it>) to detect a contact with <it>M. tuberculosis </it>hav...

Full description

Bibliographic Details
Main Authors: Seppälä Ilkka, Salo Eeva, Tavast Esko, Tuuminen Tamara
Format: Article
Language:English
Published: BMC 2009-01-01
Series:BMC Research Notes
Online Access:http://www.biomedcentral.com/1756-0500/2/9
id doaj-daa15ad08d4b4af792b4bf5a8b1d5ff5
record_format Article
spelling doaj-daa15ad08d4b4af792b4bf5a8b1d5ff52020-11-25T01:46:19ZengBMCBMC Research Notes1756-05002009-01-0121910.1186/1756-0500-2-9IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in FinlandSeppälä IlkkaSalo EevaTavast EskoTuuminen Tamara<p>Abstract</p> <p>Background</p> <p>Two commercial interferon gamma release assays (IGRAs) (QuantiFERON<sup>®</sup>-TB Gold in Tube and T SPOT<sup>®</sup>-<it>TB</it>) to detect a contact with <it>M. tuberculosis </it>have recently become available. The majority of studies agree that the sensitivity and specificity of these methods are superior to the Tuberculin Skin Tests (TSTs) in detecting an exposure to bacteria in latently infected individuals and in clinical tuberculosis. However, the data in children remains limited.</p> <p>Findings</p> <p>Consecutively collected samples from children (n = 99) representing age range from zero to 18 years were analyzed in a retrospective non-blinded study. The two IGRAs were modified and adapted to the needs of Finland, a country of a low tuberculosis incidence. For 27 children, both tests were performed simultaneously and compared with the TST and clinician's diagnosis. The sensitivity, specificity, and accuracy of both IGRAs was determined. QuantiFERON TB Gold and T SPOT-TB performed (respectively) as follows: sensitivities 0.92 (95% confidence interval, CI, 0.67–0.99) and 0.85 (0.64–0.95); specificities 0.91 (0.77–0.97) and 1.00 (0.93–1.00); accuracies 0.91 (0.80–0.97) and 0.96 (0.88–0.99). This compares favorably to the TST whose known figures are 0.90, 0.95, and 0.95, respectively. The agreement between the IGRAs was high, k = 0.89. Finally, both methods agreed well with the TST, k = 0.86 for TST/QuantiFERON-TB Gold and k = 0.76 for TST/T SPOT-TB.</p> <p>Conclusion</p> <p>The sensitivity and specificity of IGRA methods compares well with the TST without the inconveniences and complications associated with TST, including exaggerated delayed type hypersensitivity reactions. These properties place them as acceptable substitutes for TST.</p> http://www.biomedcentral.com/1756-0500/2/9
collection DOAJ
language English
format Article
sources DOAJ
author Seppälä Ilkka
Salo Eeva
Tavast Esko
Tuuminen Tamara
spellingShingle Seppälä Ilkka
Salo Eeva
Tavast Esko
Tuuminen Tamara
IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
BMC Research Notes
author_facet Seppälä Ilkka
Salo Eeva
Tavast Esko
Tuuminen Tamara
author_sort Seppälä Ilkka
title IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
title_short IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
title_full IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
title_fullStr IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
title_full_unstemmed IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland
title_sort igra tests perform similarly to tst but cause no adverse reactions: pediatric experience in finland
publisher BMC
series BMC Research Notes
issn 1756-0500
publishDate 2009-01-01
description <p>Abstract</p> <p>Background</p> <p>Two commercial interferon gamma release assays (IGRAs) (QuantiFERON<sup>®</sup>-TB Gold in Tube and T SPOT<sup>®</sup>-<it>TB</it>) to detect a contact with <it>M. tuberculosis </it>have recently become available. The majority of studies agree that the sensitivity and specificity of these methods are superior to the Tuberculin Skin Tests (TSTs) in detecting an exposure to bacteria in latently infected individuals and in clinical tuberculosis. However, the data in children remains limited.</p> <p>Findings</p> <p>Consecutively collected samples from children (n = 99) representing age range from zero to 18 years were analyzed in a retrospective non-blinded study. The two IGRAs were modified and adapted to the needs of Finland, a country of a low tuberculosis incidence. For 27 children, both tests were performed simultaneously and compared with the TST and clinician's diagnosis. The sensitivity, specificity, and accuracy of both IGRAs was determined. QuantiFERON TB Gold and T SPOT-TB performed (respectively) as follows: sensitivities 0.92 (95% confidence interval, CI, 0.67–0.99) and 0.85 (0.64–0.95); specificities 0.91 (0.77–0.97) and 1.00 (0.93–1.00); accuracies 0.91 (0.80–0.97) and 0.96 (0.88–0.99). This compares favorably to the TST whose known figures are 0.90, 0.95, and 0.95, respectively. The agreement between the IGRAs was high, k = 0.89. Finally, both methods agreed well with the TST, k = 0.86 for TST/QuantiFERON-TB Gold and k = 0.76 for TST/T SPOT-TB.</p> <p>Conclusion</p> <p>The sensitivity and specificity of IGRA methods compares well with the TST without the inconveniences and complications associated with TST, including exaggerated delayed type hypersensitivity reactions. These properties place them as acceptable substitutes for TST.</p>
url http://www.biomedcentral.com/1756-0500/2/9
work_keys_str_mv AT seppalailkka igratestsperformsimilarlytotstbutcausenoadversereactionspediatricexperienceinfinland
AT saloeeva igratestsperformsimilarlytotstbutcausenoadversereactionspediatricexperienceinfinland
AT tavastesko igratestsperformsimilarlytotstbutcausenoadversereactionspediatricexperienceinfinland
AT tuuminentamara igratestsperformsimilarlytotstbutcausenoadversereactionspediatricexperienceinfinland
_version_ 1725020233661415424